TRACY YAGER: Open Payments
NPI 1689068611 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,513 in 58 payments from 17 companies in 2025. Trend: 2023 $2,097 · 2024 $1,193 · 2025 $1,513
Food & beverage: $1,382Education: $131
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $278 |
| AstraZeneca Pharmaceuticals LP | 8 | $195 |
| CSL Behring | 8 | $178 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $120 |
| PFIZER INC. | 4 | $104 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $93 |
| GENZYME CORPORATION | 2 | $83 |
| Amgen Inc. | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $68 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, Andembry, CIBINQO, Hizentra, TAKHZYRO, EBGLYSS.
Industry payments across MD — which companies pay providers there.
